Report Detail

Pharma & Healthcare Global Oligonucleotides Market Insights, Forecast to 2025

  • RnM2438658
  • |
  • 07 May, 2019
  • |
  • Global
  • |
  • 121 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.

Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.

Oligonucleotide is widely used in Research, Pharmaceutical and Diagnostic. The most proportion of Oligonucleotide used in Research, and the revenue in 2018 is 409.97 M USD. Moreover, increase in focus on targeted gene therapies has revolutionized treatment of incurable conditions caused by genetic mutations. Increase in demand for sequencing applications by clinical, diagnostic, academic, and drug development is witnessed by manufactures.
North America is the largest customer of Oligonucleotide, with a revenue market share nearly 37.51% in 2018. Europe is the second largest consumer of Oligonucleotide, enjoying revenue market share nearly 30.5% in 2018. Asian countries are recognized as the fastest adopters of sequencing, array technology, and PCR products due to rapid progress in genomics studies and the healthcare sector. Japan and China are considered as the most attractive markets with respect to expansion and growth opportunities present in these countries. In addition, changing economic scenario, along with high investments in healthcare, life science-related research programs, and genetics, has encouraged global players to enter the Asia Pacific market, thus aiding its growth.
Global Oligonucleotides market size will increase to 1813.8 Million US$ by 2025, from 926 Million US$ in 2018, at a CAGR of 10.1% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Oligonucleotides.

This report researches the worldwide Oligonucleotides market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Oligonucleotides breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The following manufacturers are covered in this report:
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems

Oligonucleotides Breakdown Data by Type
DNA Oligos
RNA Oligos
Oligonucleotides Breakdown Data by Application
Pharmaceutical
Research
Diagnostic

Oligonucleotides Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

Oligonucleotides Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Rest of Middle East & Africa

The study objectives are:
To analyze and research the global Oligonucleotides capacity, production, value, consumption, status and forecast;
To focus on the key Oligonucleotides manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Oligonucleotides :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    Global Oligonucleotides Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

      1 Study Coverage

      • 1.1 Oligonucleotides Product Introduction
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Oligonucleotides Market Size Growth Rate by Type
        • 1.4.2 DNA Oligos
        • 1.4.3 RNA Oligos
      • 1.5 Market by Application
        • 1.5.1 Global Oligonucleotides Market Size Growth Rate by Application
        • 1.5.2 Pharmaceutical
        • 1.5.3 Research
        • 1.5.4 Diagnostic
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Oligonucleotides Production
        • 2.1.1 Global Oligonucleotides Revenue 2014-2025
        • 2.1.2 Global Oligonucleotides Production 2014-2025
        • 2.1.3 Global Oligonucleotides Capacity 2014-2025
        • 2.1.4 Global Oligonucleotides Marketing Pricing and Trends
      • 2.2 Oligonucleotides Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Oligonucleotides Manufacturers
          • 2.3.2.1 Oligonucleotides Manufacturing Base Distribution, Headquarters
          • 2.3.2.2 Manufacturers Oligonucleotides Product Offered
          • 2.3.2.3 Date of Manufacturers Enter into Oligonucleotides Market
      • 2.4 Market Drivers, Trends and Issues

      3 Market Size by Manufacturers

      • 3.1 Oligonucleotides Production by Manufacturers
        • 3.1.1 Oligonucleotides Production by Manufacturers
        • 3.1.2 Oligonucleotides Production Market Share by Manufacturers
        • 3.1.3 Global Market Concentration Ratio (CR5 and HHI)
      • 3.2 Oligonucleotides Revenue by Manufacturers
        • 3.2.1 Oligonucleotides Revenue by Manufacturers (2014-2019)
        • 3.2.2 Oligonucleotides Revenue Share by Manufacturers (2014-2019)
        • 3.2.3 Global Oligonucleotides Market Concentration Ratio (CR10 and HHI)
      • 3.3 Oligonucleotides Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Oligonucleotides Production by Regions

      • 4.1 Global Oligonucleotides Production by Regions
        • 4.1.1 Global Oligonucleotides Production Market Share by Regions
        • 4.1.2 Global Oligonucleotides Revenue Market Share by Regions
      • 4.2 United States
        • 4.2.1 United States Oligonucleotides Production
        • 4.2.2 United States Oligonucleotides Revenue
        • 4.2.3 Key Players in United States
        • 4.2.4 United States Oligonucleotides Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Oligonucleotides Production
        • 4.3.2 Europe Oligonucleotides Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Oligonucleotides Import & Export
      • 4.4 China
        • 4.4.1 China Oligonucleotides Production
        • 4.4.2 China Oligonucleotides Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Oligonucleotides Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Oligonucleotides Production
        • 4.5.2 Japan Oligonucleotides Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Oligonucleotides Import & Export
      • 4.6 Other Regions
        • 4.6.1 South Korea
        • 4.6.2 India
        • 4.6.3 Southeast Asia

      5 Oligonucleotides Consumption by Regions

      • 5.1 Global Oligonucleotides Consumption by Regions
        • 5.1.1 Global Oligonucleotides Consumption by Regions
        • 5.1.2 Global Oligonucleotides Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Oligonucleotides Consumption by Application
        • 5.2.2 North America Oligonucleotides Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Oligonucleotides Consumption by Application
        • 5.3.2 Europe Oligonucleotides Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Oligonucleotides Consumption by Application
        • 5.4.2 Asia Pacific Oligonucleotides Consumption by Countries
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Oligonucleotides Consumption by Application
        • 5.5.2 Central & South America Oligonucleotides Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Oligonucleotides Consumption by Application
        • 5.6.2 Middle East and Africa Oligonucleotides Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Oligonucleotides Breakdown Dada by Type
      • 6.2 Global Oligonucleotides Revenue by Type
      • 6.3 Oligonucleotides Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Oligonucleotides Breakdown Dada by Application
        • 7.2.1 Global Oligonucleotides Consumption by Application
        • 7.2.2 Global Oligonucleotides Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 Integrated DNA Technologies
        • 8.1.1 Integrated DNA Technologies Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Oligonucleotides
        • 8.1.4 Oligonucleotides Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 Agilent
        • 8.2.1 Agilent Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Oligonucleotides
        • 8.2.4 Oligonucleotides Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 Sigma-aldrich
        • 8.3.1 Sigma-aldrich Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Oligonucleotides
        • 8.3.4 Oligonucleotides Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 Eurofins Genomics
        • 8.4.1 Eurofins Genomics Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Oligonucleotides
        • 8.4.4 Oligonucleotides Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 L.G.C Biosearch Technologies
        • 8.5.1 L.G.C Biosearch Technologies Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Oligonucleotides
        • 8.5.4 Oligonucleotides Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 Eurogentec S.A
        • 8.6.1 Eurogentec S.A Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Oligonucleotides
        • 8.6.4 Oligonucleotides Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 Nitto Denko Avecia Inc
        • 8.7.1 Nitto Denko Avecia Inc Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Oligonucleotides
        • 8.7.4 Oligonucleotides Product Description
        • 8.7.5 SWOT Analysis
      • 8.8 GenScript
        • 8.8.1 GenScript Company Details
        • 8.8.2 Company Description
        • 8.8.3 Capacity, Production and Value of Oligonucleotides
        • 8.8.4 Oligonucleotides Product Description
        • 8.8.5 SWOT Analysis
      • 8.9 BBI Life Sciences
        • 8.9.1 BBI Life Sciences Company Details
        • 8.9.2 Company Description
        • 8.9.3 Capacity, Production and Value of Oligonucleotides
        • 8.9.4 Oligonucleotides Product Description
        • 8.9.5 SWOT Analysis
      • 8.10 GeneDesign
        • 8.10.1 GeneDesign Company Details
        • 8.10.2 Company Description
        • 8.10.3 Capacity, Production and Value of Oligonucleotides
        • 8.10.4 Oligonucleotides Product Description
        • 8.10.5 SWOT Analysis
      • 8.11 TriLink BioTechnologies
      • 8.12 SGS DNA
      • 8.13 LC Sciences
      • 8.14 Twist Bioscience
      • 8.15 Creative Biogene
      • 8.16 General Biosystems

      9 Production Forecasts

      • 9.1 Oligonucleotides Production and Revenue Forecast
        • 9.1.1 Global Oligonucleotides Production Forecast 2019-2025
        • 9.1.2 Global Oligonucleotides Revenue Forecast 2019-2025
      • 9.2 Oligonucleotides Production and Revenue Forecast by Regions
        • 9.2.1 Global Oligonucleotides Revenue Forecast by Regions
        • 9.2.2 Global Oligonucleotides Production Forecast by Regions
      • 9.3 Oligonucleotides Key Producers Forecast
        • 9.3.1 United States
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Oligonucleotides Production Forecast by Type
        • 9.4.2 Global Oligonucleotides Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Oligonucleotides Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Oligonucleotides Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Oligonucleotides Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Oligonucleotides Consumption Forecast by Countries 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Oligonucleotides Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Oligonucleotides Consumption Forecast by Countries 2019-2025
        • 10.7.2 Middle East and Africa
        • 10.7.3 Turkey
        • 10.7.4 GCC Countries
        • 10.7.5 Egypt
        • 10.7.6 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Oligonucleotides Upstream Market
        • 11.1.1 Oligonucleotides Key Raw Material
        • 11.1.2 Typical Suppliers of Key Oligonucleotides Raw Material
        • 11.1.3 Oligonucleotides Raw Material Market Concentration Rate
      • 11.2 Oligonucleotides Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Oligonucleotides Distributors
      • 11.5 Oligonucleotides Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
            • 14.1.1.1 Research Programs/Design
            • 14.1.1.2 Market Size Estimation
            • 14.1.1.3 Market Breakdown and Data Triangulation
          • 14.1.2 Data Source
            • 14.1.2.1 Secondary Sources
            • 14.1.2.2 Primary Sources
        • 14.2 Author Details

        Summary:
        Get latest Market Research Reports on Oligonucleotides . Industry analysis & Market Report on Oligonucleotides is a syndicated market report, published as Global Oligonucleotides Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Oligonucleotides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,900.00
        $5,850.00
        $7,800.00
        3,112.20
        4,668.30
        6,224.40
        3,642.60
        5,463.90
        7,285.20
        609,453.00
        914,179.50
        1,218,906.00
        325,611.00
        488,416.50
        651,222.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report